To determine whether AURKB, BUB1, and KIF1C are MYCN target genes, we performed ChIP-PCR and demonstrated a 4-to-10-fold enrichment of MYCN binding to the promoter regions in two MYCN-amplified neuroblastoma cell lines (Figure 3J). The gene discussed is MYCN; the disease is neuroblastoma.